Document Detail


Recovery of vision after adjuvant thalidomide in a child with tuberculous meningitis and acute lymphoblastic leukemia.
MedLine Citation:
PMID:  19182153     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 7-year-old child, on maintenance chemotherapy for acute lymphoblastic leukemia, developed tuberculous meningitis complicated by progressive basal meningeal inflammation and abscess formation, in spite of adequate tuberculosis treatment and adjunctive corticosteriod therapy. The child became blind as a result of involvement of the optic chiasm. After 2 months of adjunctive thalidomide therapy, the child regained vision and cranial magnetic resonance imaging showed marked reduction of the inflammatory changes previously demonstrated. Progression of intracranial tuberculous infection, in spite of a treatment that is generally considered to be adequate, is well recognized. Previous reports of a possible beneficiary role of thalidomide in these cases support an immunological basis. The present case suggests a role for thalidomide in the treatment of blindness due to involvement of the optic chiasm in progressive basal tuberculous meningitis.
Authors:
Daniela Cristina Stefan; Savvas Andronikou; Nicola Freeman; Johan Schoeman
Related Documents :
12843113 - Neonatal sepsis caused by streptococcus bovis variant (biotype ii/2): report of a case ...
8211343 - Staphylococcus aureus meningitis associated with pyogenic infection of the sacroiliac j...
6203293 - Angioendotheliosarcoma of the nose--a case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of child neurology     Volume:  24     ISSN:  1708-8283     ISO Abbreviation:  J. Child Neurol.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-02     Completed Date:  2009-05-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8606714     Medline TA:  J Child Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  166-9     Citation Subset:  IM    
Affiliation:
Department of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Tygerberg Children's Hospital, Cape Town, South Africa. cs@sun.ac.za
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Cortex Hormones / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Blindness / drug therapy*,  etiology
Brain / drug effects,  pathology
Chemotherapy, Adjuvant
Child
Humans
Immunosuppressive Agents / therapeutic use
Magnetic Resonance Imaging
Male
Optic Chiasm / drug effects,  physiopathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*,  drug therapy,  physiopathology
Recovery of Function / drug effects
Thalidomide / therapeutic use*
Tuberculosis, Meningeal / complications*,  pathology,  physiopathology
Vision, Ocular / drug effects*
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Immunosuppressive Agents; 50-35-1/Thalidomide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Visual fixation in Chiari type II malformation.
Next Document:  Tourette syndrome and comorbid pervasive developmental disorders.